AI

It has demonstrated high accuracy in detecting pancreatic cancer by extracting and analysing 260,000 metabolic signals from just 500 microlitres of blood serum.

Virginia Halsey of FDB explains how Model Context Protocols set limits for AI models so they defer to human clinical judgment rather than guessing at answers. This prevents hallucinations that can impact patient safety.

Also, Wellumio has received $4 million in pre-Series A funding to further develop its portable, AI-augmented brain scanner.

A neurologist's startup has developed a foundation model, based on 60,000 hours of brain wave records, which reportedly achieved 95% accuracy in identifying epilepsy biomarkers.

Dan Walsh, chief information security officer of Datavant, sat down with MobiHealthNews in-person to discuss AI and its evolution compared to other tech.

Shlomi Madar, CEO of SpotitEarly, discusses the company's noninvasive test using a breath sample, which is analyzed by specially trained dogs capable of identifying unique cancer-related scent signatures combined with AI technology.

Abhinav Shashank, Innovaccer CEO and cofounder, highlights the company's recently published manifesto, Autonomous Healthcare, and previews his upcoming HIMSS26 panel with other unicorn founders on tackling challenges in health tech.

Esther Kim, head of emerging technologies and solutions at Mass General Brigham, speaks with MobiHealthNews about evaluating new technologies through an operational lens and balancing innovation with real-world feasibility.

CMS Administrator Dr. Mehmet Oz said AI avatars could support early mental health intakes and flag subtle cues alongside clinical oversight.

Also, Ubie is collaborating with Mayo Clinic on a new unified patient digital front door.